Related Experiment Video

Updated: May 26, 2026

Artificial Antigen Presenting Cell (aAPC) Mediated Activation and Expansion of Natural Killer T Cells
13:18

Artificial Antigen Presenting Cell (aAPC) Mediated Activation and Expansion of Natural Killer T Cells

Published on: December 29, 2012

CEACAM1 dampens antitumor immunity by down-regulating NKG2D ligand expression on tumor cells

Zhangguo Chen1, Lanfen Chen, Kristi Baker

  • 1Gastroenterology Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

The Journal of Experimental Medicine
|December 7, 2011
PubMed

Insights

Carcinoembryonic antigen (CEA)-related cell adhesion molecule 1 (CEACAM1) on tumor cells retains NKG2D ligands, enabling immune evasion. Silencing CEACAM1 increases NKG2D ligands, enhancing natural killer cell-mediated tumor rejection.

Area of Science:

  • Immunology
  • Oncology
  • Cell Biology

Background:

  • Carcinoembryonic antigen (CEA)-related cell adhesion molecule 1 (CEACAM1) is increasingly linked to poor prognosis and metastasis in cancer.
  • The precise role of CEACAM1 in tumor immune evasion remains incompletely understood.

Purpose of the Study:

  • To investigate the functional consequences of CEACAM1 expression on tumor cells.
  • To elucidate the mechanism by which CEACAM1 influences tumor cell interactions with the immune system.

Main Methods:

  • Examined CEACAM1 expression in mouse and human tumor cells.
  • Assessed the effect of CEACAM1 on the cell surface expression of NKG2D ligands.
  • Evaluated the sensitivity of CEACAM1-silenced tumor cells to natural killer (NK) cell-mediated killing in vitro and in vivo.

Main Results:

  • Tumor-associated CEACAM1 promotes the intracellular retention of NKG2D ligands.
  • CEACAM1-silenced tumor cells display increased NKG2D ligand expression on their surface.
  • Reduced CEACAM1 expression enhances tumor cell susceptibility to NK cell-mediated cytolysis and rejection.

Conclusions:

  • CEACAM1 acts as a novel mechanism for tumor cells to evade immune surveillance by retaining NKG2D ligands.
  • Targeting CEACAM1 may represent a potential strategy to enhance anti-tumor immunity.

More Related Videos

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker07:47

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker

Published on: September 15, 2023

Related Concept Videos

Immunoglobulin-like Cell Adhesion Molecules01:31

Immunoglobulin-like Cell Adhesion Molecules

Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...